0001415889-23-014916.txt : 20231108
0001415889-23-014916.hdr.sgml : 20231108
20231108175547
ACCESSION NUMBER: 0001415889-23-014916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231106
FILED AS OF DATE: 20231108
DATE AS OF CHANGE: 20231108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lentini Renee
CENTRAL INDEX KEY: 0001838777
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17999
FILM NUMBER: 231389448
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ImmunoGen, Inc.
CENTRAL INDEX KEY: 0000855654
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 042726691
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781)895-0600
MAIL ADDRESS:
STREET 1: 830 WINTER ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOGEN INC
DATE OF NAME CHANGE: 19920703
4
1
form4-11082023_101139.xml
X0508
4
2023-11-06
0000855654
ImmunoGen, Inc.
IMGN
0001838777
Lentini Renee
C/O IMMUNOGEN, INC.
830 WINTER STREET
WALTHAM
MA
02451
false
true
false
false
VP & PRIN ACCTG OFFICER
0
Common Stock
2023-11-06
4
M
0
9000
10.79
A
108017
D
Common Stock
2023-11-06
4
M
0
2619
2.68
A
110636
D
Common Stock
2023-11-06
4
M
0
23000
10.65
A
133636
D
Common Stock
2023-11-06
4
M
0
14373
5.25
A
148009
D
Common Stock
2023-11-06
4
M
0
4024
6.98
A
152033
D
Common Stock
2023-11-06
4
M
0
55550
7.69
A
207583
D
Common Stock
2023-11-06
4
M
0
11962
5.32
A
219545
D
Common Stock
2023-11-06
4
S
0
219545
15.29
D
0
D
Stock Option (right to buy)
10.79
2023-11-06
4
M
0
9000
0
D
2024-07-17
Common Stock
9000
0
D
Stock Option (right to buy)
2.68
2023-11-06
4
M
0
2619
0
D
2026-09-30
Common Stock
2619
0
D
Stock Option (right to buy)
10.65
2023-11-06
4
M
0
23000
0
D
2028-02-15
Common Stock
23000
0
D
Stock Option (right to buy)
5.25
2023-11-06
4
M
0
14373
0
D
2029-01-31
Common Stock
14373
0
D
Stock Option (right to buy)
6.98
2023-11-06
4
M
0
4024
0
D
2031-01-08
Common Stock
4024
12625
D
Stock Option (right to buy)
7.69
2023-11-06
4
M
0
55550
0
D
2031-02-05
Common Stock
55550
25250
D
Stock Option (right to buy)
5.32
2023-11-06
4
M
0
11962
0
D
2032-02-04
Common Stock
11962
53831
D
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
This option was granted on 7/17/2014 and is fully vested as of the transaction date.
This option was granted on 9/30/2016 and is fully vested as of the transaction date.
This option was granted on 2/15/2018 and is fully vested as of the transaction date.
This option was granted on 1/31/2019 and is fully vested as of the transaction date.
This option was granted on 1/8/2021 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
This option was granted on 2/5/2021 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
This option was granted on 2/4/2022 and is exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
/s/ Renee Lentini
2023-11-08